DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/a51403/company_scan_alem) has announced the addition of the "Company Scan: Alembic Pharmaceuticals Ltd" company profile to their offering.
Company Business Description, Financial Statements, Recent News, Biopharmaceutical Industry Overview, Future Outlook
Alembic Pharmaceuticals Ltd (APL) is an Indian pharmaceutical major, with dominance in the Macrolides segment of anti-infective drugs in the country. Over the last couple of years, APL has grown its life style portfolio in Diabetes, Cardiovascular, Gynaecology, Opthalmics, Ortho and Urology. The company derives 57% of its revenues from its `7 billion domestic branded formulation business while it's `3 billion API business and `2 billion generics business is gaining good traction.
Key Topics Covered:
- Company business description
- Financial statements
- Recent news
- Biopharmaceutical industry overview
- Future outlook
For more information visit http://www.researchandmarkets.com/research/a51403/company_scan_alem